Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • 21 - Addressing cannabis use in people with psychosis

  • Edited by David Castle, University of Melbourne, Robin M. Murray, Deepak Cyril D'Souza, Yale University, Connecticut
  • Book:
    Marijuana and Madness
    Published online:
    05 November 2011
    Print publication:
    27 October 2011, pp 225-233

  • Summary

    Studies that provide mechanistic evidence delineating how the enhancement of the risk of psychosis by cannabis may be mediated at the neural level in humans are important. The modulatory effects of tetrahydrocannabinol (THC) on medial temporal, anterior cingulate/medial prefrontal and striatal activation during verbal learning were observed in the absence of differential task performance between the drug conditions. This chapter summarizes the evidence from studies that have examined the acute neural effects of cannabis and its main psychoactive ingredients during cognitive tasks, as well as on resting state activity of the brain. The acute effects of cannabis on neural activity during cognitive processing paradigms apart from learning have been examined by few other studies. Studies are underway that aim to provide mechanistic insights into the genetic modulation of the acute symptomatic, cognitive and neural effects of cannabis in humans.